Novel endothelin antagonists claimed for cardiovascular, cerebrovascular and other disorders Nov. 6, 1998 No Comments
Ribozyme oligonucleotides against apo(a) as novel therapeutic strategy for cardiovascular diseases Nov. 5, 1998 No Comments
Optimal dosing regimen for 5G1.1-SC in heart attack under evaluation in phase I trial Nov. 4, 1998 No Comments
Suntory describes new series for cardio- and cerebrovascular and peripheral circulatory disorders Nov. 3, 1998 No Comments
Cardioprotective effects of carvedilol metabolite are less potent than those of the parent drug Nov. 3, 1998 No Comments
Continuing efforts at Parke-Davis result in structurally novel functional ETA receptor antagonist Nov. 2, 1998 No Comments
RSS